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Abstract Vascular endothelial growth factor (VEGF), an
essential regulator of angiogenesis during early development as
well as during the growth of solid tumours, bears an unusually
large 5P untranslated region (5P-UTR) in the mRNA of over 1000
nucleotides. We found that the VEGF 5P-UTR, despite being
GC-rich and containing an upstream short open reading frame,
promotes efficient translation of a luciferase reporter. The
VEGF 5P-UTR also allowed translation of luciferase from a
dicistronic mRNA when placed between the two cistrons,
demonstrating that it contains an internal ribosome entry site.
Deletion analysis indicated that the IRES resides towards the 3P
end of the 5P-UTR.
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1. Introduction
All tissues, as they develop, must acquire a vasculature to
deliver an adequate supply of blood, without which the tissue
would be deprived of oxygen and nutrients. Vascular endo-
thelial growth factor (VEGF) is an important initiator of vas-
cular development both during normal development and,
pathologically, during the growth of solid cancers. The e¡ects
of VEGF during early development appear to be highly dose-
dependent because even in heterozygous form the VEGF
knockout is lethal in the embryo due to inadequate develop-
ment of blood vessels [1,2]. The crucial role of VEGF in
tumour development is demonstrated by animal studies in
which abrogation of VEGF signalling has been shown to
abolish tumour establishment and progression [3,4].
VEGF is encoded by a single gene which gives rise to four
isoforms (three isoforms in mouse) by alternative splicing
[5,6]. All four isoforms share the same 5P untranslated region
(UTR), which is unusually long (1014 nucleotides), suggesting
that elements regulating translation and/or stability of the
mRNA may reside in this region. The VEGF 5P-UTR is not
only very long, but it is also GC-rich and contains an AUG
triplet upstream of the actual initiation codon. These features
suggest translation of the VEGF mRNA would be ine⁄cient
if translation occurred by the usual mechanism, which in-
volves binding of the small ribosomal subunit complex at
the mRNA 5P cap, followed by scanning for the initiation
codon. Upstream AUGs tend to occur in mRNAs that encode
key regulatory molecules and are postulated to limit produc-
tion of proteins that would be deleterious if produced in ex-
cess [7]. However, an alternative mode of translation initiation
has recently been described that avoids the requirement for
the ribosome to commence scanning at the 5P end of the
mRNA. Some viral mRNAs and a few cellular mRNAs con-
tain an RNA structure, called the internal ribosome entry site
(IRES), that allows ribosomes to bind and initiate translation
internally within the mRNA (reviewed in [8,9]). It has not
been clear why some cellular mRNAs use internal ribosome
entry to initiate translation, but two di¡erences from cap-de-
pendent translation are likely to be signi¢cant. Firstly, IRES-
mediated translation does not involve the cap-binding trans-
lation initiation factor eIF4E, the availability of which is regu-
lated by binding proteins and by direct phosphorylation in
response to various physiological stimuli, including growth
factors [10]. Consequently, IRES-containing mRNAs will be
immune to changes in eIF4E availability. Secondly, an IRES
can allow the 43S ribosome complex to bind at or near the
initiation codon, thereby avoiding the in£uence of upstream
structures or short open reading frames in the mRNA.
We report here that the VEGF 5P-UTR can mediate trans-
lation initiation via internal ribosome entry and that the IRES
is located in the AUG-proximal region of the 5P-UTR. The
major inducing stimulus for VEGF secretion by tumours is
hypoxia and nutrient starvation in the undervascularised re-
gions of the growing tumour [11^13]. Because overall protein
synthesis is suppressed by hypoxia [14], the alternative mode
of translation initiation of VEGF synthesis may allow VEGF
production to escape this general suppression of translation.
2. Materials and methods
2.1. Plasmid construction
Plasmids used in these experiments were made by ¢rst cloning the
required elements into pBluescript SK (Stratagene), and then trans-
ferring the completed insert to expression vectors pRc/CMV or
pCDNA3 (Invitrogen). The complete 5P-UTR of the murine VEGF
gene [6] was PCR ampli¢ed from plasmid pV5NBgl63 [15] using Pfu
polymerase (Stratagene) following manufacturer’s speci¢cations with
oligonucleotide primers (forward primer: 5P-TCTAGAAGCTTAGC-
GCAGAGGCTTGGGGCAGCCGA-3P and reverse primer: 5P-GA-
ATTCCATGGTTTCGGAGGCCGTCCGGG-3P). The PCR frag-
ment and pBluescript SK were digested with HindIII and EcoRI
(NEB) and ligated together to form plasmid pBSv5. Plasmid CMV-
FF contains the ¢re£y luciferase gene and was created by PCR using
Pfu polymerase with oligonucleotides speci¢c to the ¢re£y luciferase
(forward primer 5P-CCGGAAGCTTAAGCCATGGAAGACGCCA-
AAAACATAAAG-3P and reverse primer 5P-AGAATTCTGCGGCC-
GCTGAATACAGTTACATTTTAC-3P) using plasmid pGL2prom
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(Promega) as the template. The 1660-bp PCR product was cut with
HindIII and NotI and ligated into similarly cut pRc/CMV. Plasmid
pBSv5FF was created by cutting CMV-FF with NcoI and NotI fol-
lowed by isolation of a 1660-bp fragment (containing the ¢re£y luci-
ferase) and ligation into NcoI/NotI cut pBSv5, joining the VEGF 5P-
UTR in frame with the ¢re£y luciferase gene at the ATG. Plasmid
v5FF was created by removing the insert from pBSv5FF with KpnI
and NotI and ligating into pCDNA3 also cut with KpnI and NotI.
Stem loop constructs used in expression experiments were created
using oligonucleotides designed to complement the pRc/CMV- and
pCDNA3-derived sequence to form a 45-base pair stable stem loop,
starting at the transcription start site. Forward oligo (5P-A-
GCTTGAGTCGTATTAATTTCGATAAGCCAGTAAGCAGTGG-
GTTCTCTGCGGCCGC-3P) and reverse oligo (5P-AGCTGCG-
GCCGCAGAGAACCCACTGCTTACTGGCTTATCGAAATTAA-
TACGACTCA-3P) were kinased, annealed together, and ligated into
HindIII-digested CMV-FF and v5FF to form plasmids SLFF and
SLv5FF.
Plasmid pBSRLv5FF, containing the entire dicistronic insert, was
created by isolating a 947-bp fragment (containing the Renilla lucifer-
ase gene) from NheI and XbaI digested pRL-TK (Promega), blunt
ending the fragment with T4 DNA polymerase (NEB) according to
manufacturer’s speci¢cations, and ligating into pBSv5FF cut with
HindIII and similarly blunt ended. Plasmid RLv5FF was created by
removing the insert from pBSRLv5FF with KpnI and NotI, and ligat-
ing into similarly cut pCDNA3.
Deletion constructs were assembled in pBluescript, and then the
entire insert was transferred into pCDNA3 in the same manner as
described for RLv5FF. RLv5B/E-FF was made by cutting
pBSRLv5FF with BsaI and EagI, blunt ending, and isolating a 496-
bp fragment. This fragment was cloned into pBSRLv5FF cut with
PstI and NcoI (to remove the v5), followed by blunt ending.
RLv5A/N-FF was made by cutting pBSRLv5FF with AvaII, blunt
ending, cutting with NcoI, and isolating a 550-bp fragment, which
was cloned into pBSRLv5FF cut with PstI, blunt ended, and cut
with NcoI.
2.2. Sequencing
Sequencing was performed using the ABI Prism Dye Terminator
Cycle Sequencing Ready Reaction Kit (Perkin Elmer), following man-
ufacturer’s speci¢cations. Inserts were sequenced in pCDNA3 using
T7 and SP6 primers. Deletions were sequenced to con¢rm identity
using primers speci¢c to the 3P end of RL (5P-GATGCACCTGATG-
AAATGGG-3P) and the 5P end of FF (5P-TTATGCAGTTGCTCTC-
CAGC-3P).
2.3. Cell culture and transfection
BALB/c 3T3 ¢broblasts were cultured in Dulbecco’s modi¢ed Ea-
gle’s medium (DMEM) with 10 mM HEPES, 7.5% heat inactivated
fetal calf serum, 1.2 Wg/ml penicillin, 1.6 Wg/ml gentamycin, and 200
nM additional L-glutamine. Transient transfections were performed
using lipofectin (Gibco-BRL) as recommended by the manufacturer.
Stable polyclonal lines of dual luciferase constructs were made by
CaPO4 transfection of 1U106 cells with 20 mg ScaI linearised plas-
mid, followed by selection in 0.5 mg/ml G418 (geneticin, Gibco-BRL)
for 14 days. The resultant polyclonal lines were maintained in 0.25
mg/ml G418.
2.4. Luciferase assays
Fire£y luciferase from monocistronic constructs was assayed as
described [16], but using 40 Wg protein in an assay volume of 200
Wl. The reactions were initiated by addition of 40 Wl of 1 mM D-
luciferin. The light signal was measured using a Top-Count (Packard).
The dual luciferase assays for dicistronic constructs were performed
following speci¢cations by Promega. The light signal was measured
using a scintillation counter with the coincidence circuit switched o¡.
2.5. RNA isolation and RNase protection assay
RNA was isolated by the method of Chomczynski and Sacchi [17].
Luciferase and GAPDH transcripts were quantitated by RNase pro-
tection assay using complementary RNA probes synthesised with SP6
RNA polymerase from ClaI-restricted CMV-FF and with T7 RNA
polymerase from DdeI-restricted pGAPM, respectively, essentially as
described [18]. Signals were quantitated by phosphorimaging (Molec-
ular Dynamics).
3. Results
3.1. The VEGF 5P-UTR allows e⁄cient translation
To investigate the in£uence the long VEGF 5P-UTR has on
translation we compared the translational e⁄ciency of lucifer-
ase mRNA with and without insertion of the VEGF 5P-UTR.
The complete VEGF 5P-UTR was inserted into CMV-FF
(Fig. 1) so that the luciferase initiation codon replaced the
VEGF initiation codon, thereby creating v5FF. The CMV-
FF and v5FF transcripts have 60 nucleotides in common at
the 5P end that are derived from the Rc/CMV expression
vector. The luciferase reporter genes were transiently trans-
fected into BALB/c 3T3 ¢broblasts and two days later the
levels of reporter mRNA and enzyme activity were measured.
Contrary to expectation, insertion of the VEGF 5P-UTR had
no inhibitory e¡ect on the ratio of luciferase activity to
mRNA (Fig. 1), indicating that the long VEGF 5P-UTR al-
lows translation to proceed e⁄ciently.
3.2. The VEGF 5P-UTR contains an internal ribosome
entry site
To test whether the VEGF 5P-UTR might contain an IRES
we created a large stem-loop at the very 5P end of the v5FF
mRNA by inserting 45 nucleotides of complementary se-
quence, generating SLv5FF (Fig. 1). This 5P stem-loop should
inhibit cap-dependent translation by preventing the binding of
eIF4E to the 5P cap [19]. Inhibition of cap-dependent trans-
FEBS 20787 3-9-98
Fig. 1. E¡ect of the VEGF 5P-UTR on the translational e⁄ciency
of ¢re£y luciferase. The reporter genes are shown schematically
above. All genes use the CMV promoter (CMV) and the 3P-UTR
and polyadenylation signals from the bovine growth hormone gene
(bGH). The regions coding for Renilla luciferase (RL) and ¢re£y lu-
ciferase (FF), and the VEGF 5P-UTR (v5) are indicated and the 45-
bp stem-loop at the very 5P end of SLFF and SLv5FF is shown pic-
torially. Plasmids bearing the indicated genes were transiently trans-
fected into Balb/c 3T3 ¢broblasts. Cells were lysed 48 h after trans-
fection and separate aliquots used to measure ¢re£y luciferase
mRNA by RNase protection assay and luciferase enzymatic activity.
The means and standard errors of the ratio of enzyme activity to
mRNA from 2 independent experiments are shown; note the 4-fold
change in scale for SLFF and SLv5FF. The standard errors for
SLFF and SLv5FF are too small to be evident in the ¢gure.
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lation was veri¢ed by creating the same stem-loop in the
CMV-FF mRNA, creating SLFF (Fig. 1). IRES-mediated
translation should be insensitive to such a stem-loop so long
as the stem-loop did not interfere with formation of the IRES
structure or impede access to the IRES. The presence of the
VEGF 5P-UTR allowed only partial relief of the inhibition
resulting from the stem-loop, producing a 3.2-fold increase
in translation compared to SLFF (Fig. 1). This result suggests
that the VEGF mRNA may contain an IRES but the stem-
loop structure at the 5P end of SLv5FF may interfere with its
function. Alternatively, translation of VEGF may result from
a combination of cap-mediated and IRES-mediated transla-
tion, with cap-mediated initiation predominating under the
culture conditions used in this experiment.
To further investigate the possibility that VEGF translation
can be IRES-mediated we constructed a dicistronic gene en-
coding two independently assayable enzymes, with transcrip-
tion driven by the CMV promoter (RLv5FF, Fig. 2). Nor-
mally only the upstream (5P-most) protein would be produced
from such a gene in eukaryotes because ribosomes are re-
leased at the completion of translation of the ¢rst encoded
protein. Thus, when the reporter gene is introduced into cells,
the upstream reporter (Renilla luciferase) would be synthes-
ised by normal cap-dependent translation, whereas the down-
stream reporter (¢re£y luciferase) would not be translated
unless an IRES is present in the region between the two re-
porters. The ratio of ¢re£y luciferase activity to Renilla luci-
ferase activity provides a measure of the ability of the region
inserted between the two luciferases to function as an IRES.
We inserted the entire 5P-UTR of VEGF between the two
luciferase cistrons, creating RLv5FF (Fig. 2). The dicistronic
gene was transfected into BALB/c 3T3 ¢broblasts, polyclonal
pools of stable transformants were selected and assayed for
Renilla and ¢re£y luciferase activities. For comparison we
selected a polyclonal line that had been cotransfected with
equal amounts of monocistronic luciferase reporter genes
(CMV-RL and CMV-FF, Fig. 2). The ratio of ¢re£y lucifer-
ase to Renilla luciferase was almost 3-fold greater in extracts
from cells transfected with the dicistronic gene than in extracts
from cells cotransfected with the monocistronic genes (Fig. 2),
demonstrating that the VEGF 5P-UTR can promote internal
initiation of translation. It is interesting that the VEGF IRES
appeared to function e⁄ciently in the dicistronic context (Fig.
2) but ine⁄ciently in a monocistronic context when a stable
stem-loop was inserted upstream of the VEGF 5P-UTR (Fig.
1, compare SLv5FF to v5FF). This suggests that the stem-
loop structure in SLv5FF adversely a¡ects the structure or
function of the IRES.
3.3. The IRES is located primarily in the 3P half of the VEGF
5P-UTR
IRESs were originally identi¢ed in a number of viral
mRNAs and the viral IRESs remain the best characterised.
One class of viral IRES, typi¢ed by the EMCV IRES, includes
the initiation codon at their 3P boundary, whereas the other
class can be located upstream of the initiation codon [8]. To
test whether the VEGF IRES is located near the initiation
codon we inserted into the dicistronic reporter gene either
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Fig. 3. Ratios of ¢re£y luciferase to Renilla luciferase in extracts
from cells expressing dicistronic reporters with various regions of
the VEGF 5P-UTR inserted between the luciferase cistrons. The re-
porter genes are shown schematically above. The various regions of
VEGF 5P-UTR (v5) inserted in the dicistronic genes are shown with
numbering from the ¢rst base of the VEGF 5P-UTR. Extracts were
prepared from polyclonal cell lines stably transfected with the indi-
cated dicistronic genes and the relative amounts of each luciferase
measured using the Promega dual luciferase assay. The data shown
are means and standard errors of assays in triplicate of duplicate
extracts and are representative of three cultures from the transfec-
tion.
Fig. 2. Ratios of activities of ¢re£y luciferase to Renilla luciferase
in extracts from cells expressing the two luciferase enzymes either
from separate genes or from a single dicistronic gene with the
VEGF 5P-UTR inserted between the reporters. The reporter genes
are shown schematically above. All genes use the CMV promoter
(CMV) and the 3P-UTR and polyadenylation signals from the bo-
vine growth hormone gene (bGH). The regions coding for Renilla
luciferase (RL) and ¢re£y luciferase (FF), and the VEGF 5P-UTR
(v5) are indicated. Extracts were prepared from polyclonal cell lines
stably transfected with equal amounts of plasmids bearing the
monocistronic genes (CMV-RL+CMV-FF) or the dicistronic gene
RLv5FF and the relative amounts of each luciferase measured using
the Promega dual luciferase assay. The data shown are means and
standard errors of assays in triplicate of duplicate extracts and are
representative of two cultures from the transfection.
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the 3P half of the VEGF 5P-UTR (nucleotides 474^1014, cre-
ating RLv5A/N-FF), or a central region of the 5P-UTR (nu-
cleotides 343^839, RLv5B/E-FF) (Fig. 3). In RLv5A/N-FF
the fusion of VEGF and luciferase sequences occurs precisely
at the initiation codon. The RLv5B/E-FF produced little ¢re-
£y luciferase relative to Renilla luciferase, whereas RLv5A/N-
FF produced signi¢cant levels of ¢re£y relative to Renilla
luciferase, although not as high as produced by the dicistronic
construct containing the entire VEGF 5P-UTR (Fig. 3). Thus
sequences between nucleotides 839 and 1014 are essential for
IRES function. Partial IRES function is conferred by the
region downstream of nucleotide 474, but for optimal IRES
activity sequences upstream of nucleotide 474 appear to be
necessary.
4. Discussion
Initiation of translation of most mRNAs involves binding
of the mRNA 5P cap structure by the initiation factor eIF4E.
The concentration of eIF4E in the cytoplasm is rate-limiting,
forcing mRNAs to compete for eIF4E to initiate translation,
which places limits on the production of cellular proteins.
This is particularly important for certain key regulators of
cell growth, especially those with secondary structure in the
5P-UTR, which are translated ine⁄ciently [20^22].
Viruses such as poliovirus have developed an e¡ective meth-
od to circumvent this competitive environment, allowing
translation of viral mRNAs despite limitations in the level
of eIF4E [8,9]. These viruses turn o¡ translation of host
mRNAs by cleaving eIF4G, which uncouples the cap-binding
complex from the rest of the translation initiation machinery.
The viral mRNAs continue to be translated because they con-
tain internal ribosome entry sites, which allow ribosome bind-
ing, and therefore translation, without involving the 5P cap.
To date only a few cellular mRNAs, encoding PDGF-B
[23], FGF-2 [24], IGF-II [25], immunoglobulin heavy chain
binding protein (BiP) [26], c-myc [27,28], eIF4G [29], Droso-
phila antennapedia [30], and VEGF (reported here, and in
agreement with [31]) have been found to contain an IRES.
The physiological role of these IRESs is not yet clear, but it
is striking that most are important regulatory genes, involved
in growth control. The presence of an IRES in these mRNAs
may re£ect the need to maintain translation of key survival
proteins under conditions of stress, when normal cap-depend-
ent translation is compromised. Furthermore, three of these
(bFGF, PDGF-B and VEGF) are involved in formation or
maintenance of blood vessels [11,32,33]. Since VEGF synthe-
sis is induced both by hypoxia and by nutrient deprivation,
and one function of VEGF is to stimulate angiogenesis to
restore the blood supply to ischaemic tissues, the presence
of the IRES in the 5P-UTR may be important to allow
VEGF secretion by cells that are severely starved.
The VEGF IRES may also have an important role during
embryonic development. VEGF is an essential regulator of
vascular development in the embryo, where its e¡ects appear
to be exquisitely dose-dependent, since mice with only one
functional allele of the VEGF gene die in utero from failure
of adequate vascular development [1,2]. Thus it seems likely
that VEGF must be produced at a precise rate in the devel-
oping embryo. The IRES-mediated translation of VEGF may
act as a bu¡er against changes in the cellular concentration of
eIF4E, allowing an appropriate rate of synthesis of VEGF
despite modulation of eIF4E levels in response to changes
in the cellular environment.
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